Leading coronavirus scientist, Kizzmekia S. Corbett, to join Harvard T.H. Chan School of Public Health to continue vaccine study

Harvard T.H. Chan School of Public Health today announced that Kizzmekia S. Corbett will join the School as an assistant professor in the Department of Immunology and Infectious Diseases. She will also hold an appointment at the Harvard Radcliffe Institute as the Shutzer Assistant Professor. Corbett comes to Harvard Chan School following more than six years as a research fellow at the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center, part of the National Institutes of Health (NIH), where she was instrumental in groundbreaking research that directly led to development of the Moderna COVID-19 vaccine. Her first day will be June 14, 2021.

“Vaccines are the great equalizer when it comes to addressing health disparities, especially around infectious diseases. Harvard Chan School is at the forefront of advancing health equity, and I’m excited to join such distinguished colleagues in my pursuit of viral immunology research and vaccine development,” said Corbett.

In her new role, Corbett will head the new Coronaviruses & Other Relevant Emerging Infectious Diseases (CoreID) Lab to study and understand the interface between hosts’ immune systems and viruses that cause respiratory disease, with the goal of informing development of novel and potentially universal vaccines. “If the last year has taught me anything, it’s that anything is possible,” she added.

The views and opinions expressed in the article are solely those of their authors, and do not necessarily reflect the opinions and beliefs of AcademicWomen.com.